Prestige Brand Holdings Inc Asset Resilience Ratio
Prestige Brand Holdings Inc asset resilience ratio. Prestige Brand Holdings Inc (PBH) has an Asset Resilience Ratio of 1.78% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PBH days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Prestige Brand Holdings Inc (2012–2025)
Asset resilience ratio of Prestige Brand Holdings Inc from 2012 to 2025. This chart shows how Prestige Brand Holdings Inc's Asset Resilience Ratio has changed over time. Read PBH current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Prestige Brand Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Prestige Brand Holdings Inc balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $62.37 Million | 1.78% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $62.37 Million | 1.78% |
Asset Resilience Insights
- Limited Liquidity: Prestige Brand Holdings Inc maintains only 1.78% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Prestige Brand Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Prestige Brand Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Prestige Brand Holdings Inc Asset Resilience Ratio by Year (2012–2025)
Prestige Brand Holdings Inc asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Prestige Brand Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 2.88% | $97.88 Million | $3.40 Billion | +1.48pp |
| 2024-03-31 | 1.40% | $46.47 Million | $3.32 Billion | -0.34pp |
| 2023-03-31 | 1.74% | $58.49 Million | $3.35 Billion | +1.00pp |
| 2022-03-31 | 0.74% | $27.18 Million | $3.67 Billion | -0.20pp |
| 2021-03-31 | 0.94% | $32.30 Million | $3.43 Billion | -1.75pp |
| 2020-03-31 | 2.70% | $94.76 Million | $3.51 Billion | +1.90pp |
| 2019-03-31 | 0.80% | $27.53 Million | $3.44 Billion | -0.07pp |
| 2018-03-31 | 0.87% | $32.55 Million | $3.76 Billion | -0.20pp |
| 2017-03-31 | 1.07% | $41.85 Million | $3.91 Billion | -- |
| 2016-03-31 | 0.00% | $0.00 | $2.95 Billion | -- |
| 2015-03-31 | 0.00% | $0.00 | $2.67 Billion | -- |
| 2014-03-31 | 0.00% | $0.00 | $1.80 Billion | -- |
| 2013-03-31 | 0.00% | $0.00 | $1.74 Billion | -- |
| 2012-03-31 | 0.00% | $0.00 | $1.76 Billion | -- |
About Prestige Brand Holdings Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various… Read more